FDA Inspection 870615 — Vericel Corporation

Vericel Corporation — FEI 3002836339

The FDA completed an inspection of Vericel Corporation on March 19, 2014 in Cambridge, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 19, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Cambridge, MA (United States)